| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2760 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2366 | 2020 |
| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England journal of medicine 383 (6), 517-525, 2020 | 1635 | 2020 |
| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 878 | 2021 |
| Diagnostic testing for severe acute respiratory syndrome–related coronavirus 2: a narrative review MP Cheng, J Papenburg, M Desjardins, S Kanjilal, C Quach, M Libman, ... Annals of internal medicine 172 (11), 726-734, 2020 | 858 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 678 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 391 | 2021 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 305 | 2022 |
| Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 BJ Ward, P Gobeil, A Séguin, J Atkins, I Boulay, PY Charbonneau, ... Nature medicine 27 (6), 1071-1078, 2021 | 303 | 2021 |
| Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis N Bobrovitz, RK Arora, C Cao, E Boucher, M Liu, C Donnici, ... PloS one 16 (6), e0252617, 2021 | 270 | 2021 |
| SeroTracker: a global SARS-CoV-2 seroprevalence dashboard RK Arora, A Joseph, J Van Wyk, S Rocco, A Atmaja, E May, T Yan, ... The Lancet Infectious Diseases 21 (4), e75-e76, 2021 | 246 | 2021 |
| Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study MP Cheng, R Stenstrom, K Paquette, SN Stabler, M Akhter, AC Davidson, ... Annals of internal medicine 171 (8), 547-554, 2019 | 208 | 2019 |
| Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies I Bergeri, MG Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, ... PLoS medicine 19 (11), e1004107, 2022 | 185 | 2022 |
| Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ... Clinical Microbiology and Infection 28 (8), 1076-1084, 2022 | 179 | 2022 |
| Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review MP Cheng, CP Yansouni, NE Basta, M Desjardins, S Kanjilal, K Paquette, ... Annals of internal medicine 173 (6), 450-460, 2020 | 177 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 175 | 2022 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... Cmaj 194 (7), E242-E251, 2022 | 169 | 2022 |
| Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis MP Cheng, CNA Chakra, CP Yansouni, S Cnossen, I Shrier, D Menzies, ... Clinical Infectious Diseases 64 (5), 635-644, 2017 | 143 | 2017 |
| Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® D Seidel, A Meißner, M Lackner, E Piepenbrock, J Salmanton-García, ... Critical reviews in microbiology 45 (1), 1-21, 2019 | 134 | 2019 |
Todd C. Lee MD MPH FIDSAAssociate Professor, McGill University, Montreal QCE-mail megerősítve itt: mcgill.ca